Literature DB >> 15937987

A new ligand for immunoglobulin g subdomains by screening of a synthetic peptide library.

Antonio Verdoliva1, Daniela Marasco, Antonia De Capua, Angela Saporito, Piero Bellofiore, Vincenzo Manfredi, Roberto Fattorusso, Carlo Pedone, Menotti Ruvo.   

Abstract

By screening a synthetic peptide library of general formula (NH(2)-Cys1-X2-X3-X4)(2)-Lys-Gly-OH, a disulfide-bridged cyclic peptide, where X2-X3-X4 is the tripeptide Phe-His-His, has been selected as a ligand for immunoglobulin G (IgG). The peptide, after a preliminary chromatographic characterization, has proved useful as a new affinity ligand for the purification of polyclonal as well as monoclonal antibodies from biological fluids, with recovery yields of up to 90% (90% purity). The ligand is able to bind antibody fragments containing both Fab and Fc from different antibody isotypes, a fact suggesting the presence of at least two different antibody-binding sites. While the recognition site on Fab is unknown, comparative binding studies with Fc, in association with the striking similarities of the peptide (named Fc-receptor mimetic, FcRM) with a region of the human FcgammaRIII receptor, strongly indicate that the peptide could recognize a short amino acid stretch of the lower hinge region, which has a key role in autoimmune disease triggering. The unique properties make the ligand attractive for both the purification of antibody fragments and as a lead for the generation of Fc-receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937987     DOI: 10.1002/cbic.200400368

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  8 in total

1.  Discovery and characterization of a peptide motif that specifically recognizes a non-native conformation of human IgG induced by acidic pH conditions.

Authors:  Kotaro Sakamoto; Yuji Ito; Takaaki Hatanaka; Preeti Brijiral Soni; Toshiyuki Mori; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2009-02-19       Impact factor: 5.157

2.  Antibody purification via affinity membrane chromatography method utilizing nucleotide binding site targeting with a small molecule.

Authors:  Nur Mustafaoglu; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Analyst       Date:  2016-11-28       Impact factor: 4.616

Review 3.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.

Authors:  P Mark Hogarth; Geoffrey A Pietersz
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

4.  Binding site on human immunoglobulin G for the affinity ligand HWRGWV.

Authors:  Haiou Yang; Patrick V Gurgel; D Keith Williams; Benjamin G Bobay; John Cavanagh; David C Muddiman; Ruben G Carbonell
Journal:  J Mol Recognit       Date:  2010 May-Jun       Impact factor: 2.137

Review 5.  Fc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides.

Authors:  Weonu Choe; Trishaladevi A Durgannavar; Sang J Chung
Journal:  Materials (Basel)       Date:  2016-12-08       Impact factor: 3.623

6.  Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1.

Authors:  Salvatore Ponticelli; Daniela Marasco; Valeria Tarallo; Romulo J C Albuquerque; Stefania Mitola; Atsunobu Takeda; Jean-Marie Stassen; Marco Presta; Jayakrishna Ambati; Menotti Ruvo; Sandro De Falco
Journal:  J Biol Chem       Date:  2008-10-15       Impact factor: 5.157

7.  Generation and Characterization of Monoclonal Antibodies against a Cyclic Variant of Hepatitis C Virus E2 Epitope 412-422.

Authors:  Annamaria Sandomenico; Antonio Leonardi; Rita Berisio; Luca Sanguigno; Giuseppina Focà; Annalia Focà; Alessia Ruggiero; Nunzianna Doti; Livio Muscariello; Daniela Barone; Claudio Farina; Ania Owsianka; Luigi Vitagliano; Arvind H Patel; Menotti Ruvo
Journal:  J Virol       Date:  2016-01-27       Impact factor: 5.103

Review 8.  Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.

Authors:  Gabriela R Barredo-Vacchelli; Silvana L Giudicessi; María C Martínez-Ceron; Osvaldo Cascone; Silvia A Camperi
Journal:  Int J Pept Res Ther       Date:  2021-10-19       Impact factor: 1.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.